The rising awareness about possible artificial conception methodologies and increasing incidences of advanced maternal age are driving the demand for the market.
Market Size – USD 24.21 Billion in 2019, Market Growth - CAGR of 9.9%, Market Trends – Growing health awareness. The global Assisted Reproductive Technology (ART) market is forecast to reach USD 50.71 Billion by 2027, according to a new report by Reports and Data.

Assisted reproductive technology (ART) is the treatment for infertility in which laboratory fusion of ovule extracted from the women ovaries and are mixed with the male sperms is performed. There has been a dramatic rise in the number of women who have their babies at age 35 and over in the past four decades. This progression started in the mid-1970's in the U.S. and has proceeded to grow slowly over time. Fifteen percent of birth-giving people today are 35 and older, up from 11% in 2002 and 8% in 1990. Thus, with the increasing trends of late pregnancies across different parts of the world the adoption of ovulation test kits is anticipated to grow significantly
Globally, approximately 0.3% of all infants born every year are conceived using assisted reproductive technology (ART) treatments. Moreover, growing awareness of ART and eliminated discomfort about pregnancy related disorders from social factors have contributed sufficient market boost of the ART procedures. According to the World Fertility Patterns statistics, Mexico's birth rates are about 2 kids per mother, well below the levels expected to support current Mexico's population. Brazil's birth rate is also smaller, at 1.75, close to that of 1.77 for Colombia. Costa Rica is also smaller, down from 1.66. These declining fertility rates can be threatening for woman and parents planning to conceive. Thus, more number of couples are approaching an artificial pregnancy method.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1402
The report initially offers market introduction, market overview, product scope, market opportunities, growth prospects, risks, limitations, and key drivers. The report also covers a comprehensive analysis of the competitive landscape with extensive profiling of the key competitors. It covers recent technological advancements, product developments, product launches, mergers and acquisitions, collaborations, joint ventures, and partnerships.
Top companies profiled in the report include:
Merck KGaA (Germany), Cooper Surgical (Denmark), Fujifilm Irvine Scientific (US), Vitroife AB (Sweden), Thermo Fisher Scientific (US), Celmatix, Inc. (US), Anecova (Switzerland), OvaScience (US), Ferring Pharmaceuticals (US), , and FertiPro N.V. (Belgium).
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1402
The report also covers SWOT analysis and Porter’s Five Forces analysis along with feasibility analysis and investment return analysis. Key statistical data has been organized in tables, charts, diagrams, figures, and other pictorial representations. The report also offers strategic recommendations to established players as well as details on entry barriers for new entrants.
The report covers the Assisted Reproductive Technology (ART) market on a global scale along with market breakdown into product types, applications, technology, end-user, and key regions.
Procedures Outlook (Revenue, USD Billion; 2017-2027)
• Fresh Donor
• Fresh Non-Donor
• Frozen Donor
• Frozen Non-Donor
• Embryo/Egg Banking
Technology Outlook (Revenue, USD Billion; 2017-2027)
• In-Vitro Fertilization (IVF)
o IVF Using Intra-Cytoplasmic Sperm Injection (ICSI)
o IVF Without Using Intra-Cytoplasmic Sperm Injection (ICSI)
• Pre-Implantation Genetic Screening (PGS)
• Frozen Embryo Replacement (FER)
• Others
Type Outlook (Revenue, USD Billion; 2017-2027)
• Artificial Insemination
• Surrogacy
• Ovulation Induction
• Others
End Use Outlook (Revenue, USD Billion; 2017-2027)
• Fertility Clinics
• Hospitals
• Clinical Research
• Others
Regional analysis covers:
• North America (U.S.A., Canada, Mexico)
• Europe (U.K., Italy, Germany, France, Rest of EU)
• Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
• Latin America (Chile, Brazil, Argentina, Rest of Latin America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
The study also analyses the market share, growth forecast and rate, current and future trends, market drivers and restraints, opportunities and challenges, risks, and threats. The report also covers a comprehensive analysis of the changing market dynamics and offers a futuristic outlook of industry.
To know more about the report @ https://www.reportsanddata.com/report-detail/assisted-reproductive-technology-art-market

The rising awareness about possible artificial conception methodologies and increasing incidences of advanced maternal age are driving the demand for the market. Market Size – USD 24.21 Billion in 2019, Market Growth - CAGR of 9.9%, Market Trends – Growing health awareness. The global Assisted Reproductive Technology (ART) market is forecast to reach USD 50.71 Billion by 2027, according to a new report by Reports and Data. Assisted reproductive technology (ART) is the treatment for infertility in which laboratory fusion of ovule extracted from the women ovaries and are mixed with the male sperms is performed. There has been a dramatic rise in the number of women who have their babies at age 35 and over in the past four decades. This progression started in the mid-1970's in the U.S. and has proceeded to grow slowly over time. Fifteen percent of birth-giving people today are 35 and older, up from 11% in 2002 and 8% in 1990. Thus, with the increasing trends of late pregnancies across different parts of the world the adoption of ovulation test kits is anticipated to grow significantly Globally, approximately 0.3% of all infants born every year are conceived using assisted reproductive technology (ART) treatments. Moreover, growing awareness of ART and eliminated discomfort about pregnancy related disorders from social factors have contributed sufficient market boost of the ART procedures. According to the World Fertility Patterns statistics, Mexico's birth rates are about 2 kids per mother, well below the levels expected to support current Mexico's population. Brazil's birth rate is also smaller, at 1.75, close to that of 1.77 for Colombia. Costa Rica is also smaller, down from 1.66. These declining fertility rates can be threatening for woman and parents planning to conceive. Thus, more number of couples are approaching an artificial pregnancy method. Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1402 The report initially offers market introduction, market overview, product scope, market opportunities, growth prospects, risks, limitations, and key drivers. The report also covers a comprehensive analysis of the competitive landscape with extensive profiling of the key competitors. It covers recent technological advancements, product developments, product launches, mergers and acquisitions, collaborations, joint ventures, and partnerships. Top companies profiled in the report include: Merck KGaA (Germany), Cooper Surgical (Denmark), Fujifilm Irvine Scientific (US), Vitroife AB (Sweden), Thermo Fisher Scientific (US), Celmatix, Inc. (US), Anecova (Switzerland), OvaScience (US), Ferring Pharmaceuticals (US), , and FertiPro N.V. (Belgium). Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1402 The report also covers SWOT analysis and Porter’s Five Forces analysis along with feasibility analysis and investment return analysis. Key statistical data has been organized in tables, charts, diagrams, figures, and other pictorial representations. The report also offers strategic recommendations to established players as well as details on entry barriers for new entrants. The report covers the Assisted Reproductive Technology (ART) market on a global scale along with market breakdown into product types, applications, technology, end-user, and key regions. Procedures Outlook (Revenue, USD Billion; 2017-2027) • Fresh Donor • Fresh Non-Donor • Frozen Donor • Frozen Non-Donor • Embryo/Egg Banking Technology Outlook (Revenue, USD Billion; 2017-2027) • In-Vitro Fertilization (IVF) o IVF Using Intra-Cytoplasmic Sperm Injection (ICSI) o IVF Without Using Intra-Cytoplasmic Sperm Injection (ICSI) • Pre-Implantation Genetic Screening (PGS) • Frozen Embryo Replacement (FER) • Others Type Outlook (Revenue, USD Billion; 2017-2027) • Artificial Insemination • Surrogacy • Ovulation Induction • Others End Use Outlook (Revenue, USD Billion; 2017-2027) • Fertility Clinics • Hospitals • Clinical Research • Others Regional analysis covers: • North America (U.S.A., Canada, Mexico) • Europe (U.K., Italy, Germany, France, Rest of EU) • Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC) • Latin America (Chile, Brazil, Argentina, Rest of Latin America) • Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA) The study also analyses the market share, growth forecast and rate, current and future trends, market drivers and restraints, opportunities and challenges, risks, and threats. The report also covers a comprehensive analysis of the changing market dynamics and offers a futuristic outlook of industry. To know more about the report @ https://www.reportsanddata.com/report-detail/assisted-reproductive-technology-art-market
WWW.REPORTSANDDATA.COM
Assisted Reproductive Technology (ART) Market, 2020-2027
Assisted reproductive technology (ART) market is forecasted to grow at a rate of 9.9% from USD 24.21 billion in 2019 to USD 50.71 billion in 2027. ART can be used to bypass fertility problems while conserving the genetic connection.
0 Comments 0 Shares
Sponsored